tristearin has been researched along with Atherosclerotic Parkinsonism in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cortesi, R; Drechsler, M; Esposito, E; Fantin, M; Lain, F; Mariani, P; Marti, M; Menegatti, E; Morari, M; Paccamiccio, L; Sivieri, E | 1 |
1 other study(ies) available for tristearin and Atherosclerotic Parkinsonism
Article | Year |
---|---|
Solid lipid nanoparticles as delivery systems for bromocriptine.
Topics: Absorptiometry, Photon; Animals; Antiparkinson Agents; Behavior, Animal; Bromocriptine; Chromatography, High Pressure Liquid; Cryoelectron Microscopy; Dialysis; Drug Delivery Systems; Kinetics; Light; Lipids; Male; Microscopy, Electron; Nanoparticles; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Scattering, Radiation; Spectrophotometry, Ultraviolet; Triglycerides; X-Ray Diffraction | 2008 |